Synthetic Biologics (SYN) Financials

$0.70

$-0.02 (-2.78%)

As on 05-Dec-2022 09:30EDT

Market cap

$16 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	19.52	14.27	10.16	15.66	17.57	26.25
Operating Profit (EBIT)	-19.52	-14.27	-10.16	-15.66	-17.57	-26.25
Other Income	--	--	0.04	0.28	4.15	10.76
Profit before Tax	-19.36	-14.27	-10.12	-15.38	-13.42	-15.49
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-19.36	-14.27	-10.04	-15.30	-13.37	-15.17
Minority Interest	--	0.00	-0.07	-0.08	-0.05	-0.32
Consolidated Profit	-14.50	-23.19	-12.56	-16.08	-25.29	-22.14

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	58.15	65.41	8.03	14.37	29.36	-1.50
Minority Interest	--	--	-2.77	-2.88	-2.91	-1.91
Non-Current Liabilities	7.35	1.40	0.19	0.47	0.30	12.46
Current Liabilities	13.19	3.55	2.97	5.28	3.38	9.79
Total Liabilities	13.19	70.37	8.41	17.24	30.14	18.84

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	25.96	1.51	0.48	0.81	0.63	0.90
Current Assets	52.73	68.86	7.93	16.43	29.51	17.94
Total Assets	91.89	70.37	11.18	20.11	33.05	20.75
Total Debt*	--	1.53	0.47	0.72	--	--
Net Current Assets	39.54	65.30	4.97	11.15	26.13	8.15

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-12.89	-12.17	-13.87	-17.28	-20.20
Cash Flow from Investing Activities	--	-0.01	-0.01	-0.01	-0.01	-0.21
Cash from Financing Activities	--	74.00	3.36	3.36	29.09	18.48
Net Cash Inflow / Outflow	--	--	-8.82	-13.87	11.80	-1.94

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-37.82	-85.14	-68.85	-95.93	-1,291.95
ROE (%)	-30.68	-38.85	-89.69	-69.99	-95.93	-1,291.95
ROA (%)	-22.75	-36.22	-78.32	-64.60	-54.58	-73.42
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	-22,825.00	-5,407.42	-322.10	-141.04
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-29.88	-40.49	35.13	10.86	33.07	33.12
Net Profit Growth (%)	-39.15	-42.06	34.37	-14.48	11.91	44.33
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.24	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.01	4.64	0.58	0.93	1.67	0.66
Close Price ($)	0.99	2.72	3.83	5.07	5.60	177.80
High Price ($)	4.68	17.00	7.50	8.50	210.00	367.50
Low Price ($)	0.97	2.55	2.52	3.65	5.08	143.50
Market Cap ($ Cr)	16.16	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.00	0.02	0.06	0.05	--	--
Short term debt to equity ratio	--	0.00	0.04	0.02	--	--
Current Ratio	4.00	19.37	2.67	3.11	8.72	1.83
Quick Ratio	4.00	--	--	--	--	1.83
Interest Coverage	-644.23	-2,379.00	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.